Mika Newton

Chief Executive Officer at xCures

Mika Newton is the Chief Executive Officer of xCures Inc., where they oversee an AI-assisted platform that helps cancer patients organize and structure their medical data. Prior to xCures, they served as an Advisor at MedFluencers, a healthcare marketing agency. Mika has also held positions as the Chief Commercial Officer at Doctor Evidence, LLC, the General Manager of Clinical Development Services at diaDexus, and the Senior Vice President of Client and Market Development at Evidera. Mika has extensive experience in sales and marketing, having served as the Vice President of Sales and Marketing at Archimedes - Healthcare Modeling, the Executive Director of Business Development at Quintiles, the Director of Americas Sales Operations at Life Technologies, and the Director of Discovery Research Product Sales at Tripos. Mika's career began as a Technical Sales Representative at Mallinckrodt Pharmaceuticals.

Mika Newton's education history begins in 1993 when they enrolled at Worcester Polytechnic Institute, where they pursued a Bachelor of Science degree in Biotechnology. Mika completed their studies at this institution in 1998. In 1997, Mika briefly attended The London School of Economics and Political Science (LSE), where they focused on Corporate Finance and Management Accounting. Most recently, in the year 2020, they participated in Continuing Studies at Stanford University, concentrating on Business Administration and Management.

Location

San Francisco, United States

Links

Previous companies


Org chart


Teams


Offices

This person is not in any offices


xCures

The convergence of genomics, precision medicine, and AI have created an unprecedented moment in the world of oncology. But the drug-centric way in which treatments are developed and the haphazard way in which knowledge about those treatments is captured and delivered to the point of care does not serve patients well. xCures is changing that, withan AI-based precision oncology platform that tightly integrates cancer research and care.The xCures platform runs a perpetual trial that captures Real World Evidence (RWE) to continuously learn from all patients, on all treatments, all the time. It coordinates treatment recommendations across all patients and institutions to match patients with the treatments that work. And it packages RWE for use by stakeholders across oncology, slashing the time and cost of drug development and saving lives.


Industries

Employees

11-50

Links